Fürst Medical Laboratory acquires PatoGen
Wednesday, August 4, 2021
Fürst Medical Laboratory acquired PatoGen and now owns 100% of the shares. The company will continue to develop PatoGen as a leading provider of preventive and diagnostic analysis to the growing aquaculture industry.
With experience for the past 70 years focusing on superior service and high quality in human health diagnostics, Fürst is a market leader and among the largest medical laboratory service providers in Northern Europe. “Fürst has a long-lasting and solid experience running effective laboratories and diagnostics. Becoming owners of PatoGen, we also are exposed to preventive and diagnostic analyses in fish. This is an attractive market for us, and we are confident we can make a valuable contribution to the aquaculture companies to improve their fish health and fish welfare,” said Fürst CEO, Håvard Selby Ebbestad.
The new ownership will enforce and develop PatoGen in areas like quality, capacity, technology and competence in fish health. With Fürst as owner, PatoGen will continue to be an independent diagnostic company not offering accessory products to the aquaculture companies.
Check out the latest industry job openings in our Job Board.
We are social. Connect with us on:
Sign Up For Our Publications
Select a newsletter/magazine and submit your e-mail to subscribe.